1 Min Read
May 23 (Reuters) - Valeritas Holdings Inc:
* VALERITAS’ V-GO® WEARABLE INSULIN DELIVERY DEVICE DEMONSTRATES POSITIVE CLINICAL AND ECONOMIC BENEFITS IN PATIENTS WITH TYPE 2 DIABETES Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.